References
- Frank AL, Joshi TK. The global spread of asbestos. Ann. Glob. Health. 80(4), 257–262 (2014).
- Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 21, 2636–2644 (2003).
- Buikhuisen WA, Hiddinga BI, Baas P et al. Second line therapy in malignant pleural mesothelioma: a systematic review. Lung Cancer 89(3), 223–231 (2015).
- Jacobson HI, Gupta GN, Fernandez C et al. Determination of tritium in biological material. Arch. Biochem. Biophys. 86, 89–93 (1960).
- Kuiper GG, Enmark E, Pelto-Huikko M et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA 93(12), 5925–5930 (1996).
- Yakimchuk K, Iravani M, Hasni MS et al. Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo. Leukemia 25, 1103–1110 (2011).
- Marzioni M, Torrice A, Saccomanno S et al. An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. Dig. Liver Dis. 44, 134–142 (2012).
- Jia M, Dahlman-Wright K, Gustafsson JÅ. Estrogen receptor alpha and beta in health and disease. Best Pract. Res. Clin. Endocrinol. Metab. 29(4), 557–568 (2015).
- Pinton G, Brunelli E, Murer B et al. Estrogen receptor β affects the prognosis of human malignant mesothelioma. Cancer Res. 69(11), 4598–4604 (2009).
- Manente AG, Valenti D, Pinton G et al. Estrogen receptor β activation impairs mesothelioma cell metabolism and growth in vitro and in vivo. Oncogenesis 2, e72 (2013).
- Fassina A, Cappellesso R, Guzzardo V et al. Epithelial-mesenchymal transition in malignant mesothelioma. Mod. Pathol. 25, 86–99 (2012).
- Pinton G, Thomas W, Bellini P et al. Estrogen receptor β exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib. PLoS ONE 5(11), e14110 (2010).
- Francis RJ, Segard T, Morandeau L et al. Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT. Lung Cancer 90(1), 55–60 (2015).
- Capkova L, Koubkova L, Kodet R. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study. Neoplasma 61(2), 161–169 (2014).
- Manente AG, Pinton G, Zonca S et al. Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells. Oncotarget 6(28), 25121–25134 (2015).
- Manente AG, Pinton G, Zonca S et al. KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma. Epigenomics 8(9), 1227–1238 (2016).
- Pinton G, Manente AG, Daga A et al. Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity. Mol. Cancer 13, 227 (2014).
- Warner M, Huang B, Gustafsson JA. Estrogen Receptor β as a pharmaceutical target. Trends Pharmacol. Sci. 38(1), 92–99 (2017).